📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99mTc and 188Re Theranostic Agents for Prostate Cancer. (2024)

First Author: Pham TT

Attributed to: King’s College London Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.124.267450

PubMed Identifier: 38844360

Publication URI: http://europepmc.org/abstract/MED/38844360

Type: Journal Article/Review

Volume: 65

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Issue: 7

ISSN: 0161-5505